Table 1

Inclusion and exclusion criteria

Inclusion criteriaExclusion criteria
PopulationWomen with an index diagnosis of PPCM according to the ESC position statement.Women presenting with heart failure earlier than the last month of pregnancy or women who were more than 6 months post partum.
Women with PPCM and a subsequent pregnancy.
Women with pre-existing heart disease.
Studies in which the study population is not solely PPCM and their data cannot be differentiated from other patients with heart failure of other aetiologies.
Animal studies.
OutcomeReported in-hospital complications and outcomes at a 6-month and/or 12-month follow-up visit, such as, but not limited to:
  • Death.

  • LV non-recovery.

  • Arrhythmias.

  • Stroke.

  • Thromboembolism.

No objective outcomes or complications reported for 6 months and/or 12 months.
Study designCohort studiesLetters
Cross-sectional studiesCommentaries
Retrospective studiesEditorials
Control arms of RCTsNarrative reviews
Case series (<10 patients)
Case reports
Congress abstracts
Non-placebo control arms of RCTs
Intervention arms of RCTs
LanguageNo English abstract available.
Year of publication1 January 2000–1 June 2021.Before the year 2000.
  • ESC, European Society of Cardiology; LV, left ventricular; PPCM, peripartum cardiomyopathy; RCTs, randomised controlled trials.